Terms: = Thyroid cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130 AND Treatment
4 results:
1. Construction of a prognostic model for triple-negative breast cancer based on immune-related genes, and associations between the tumor immune microenvironment and immunological therapy.
Zhu Y; Tao LF; Liu JY; Wang YX; Huang H; Jiang YN; Qian WF
Cancer Med; 2023 Jul; 12(14):15704-15719. PubMed ID: 37306188
[TBL] [Abstract] [Full Text] [Related]
2. treatment OF TOXIC thyroid ADENOMA BY THE ETHANOL DESTRUCTION METHOD.
Espenbetova M; Zhumanbayeva Z; Krykpayeva A; Amrenova K; Glushkova N
Georgian Med News; 2018 Mar; (276):81-86. PubMed ID: 29697387
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical evaluation of inflammatory and proliferative markers in adjacent normal thyroid tissue in patients undergoing total thyroidectomy: results of a preliminary study.
Ardito G; Revelli L; Boninsegna A; Sgambato A; Moschella F; Marzola MC; Giustozzi E; Avenia N; Castelli M; Rubello D
J Exp Clin Cancer Res; 2010 Jun; 29(1):77. PubMed ID: 20565793
[TBL] [Abstract] [Full Text] [Related]
4. Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
Park JI; Strock CJ; Ball DW; Nelkin BD
Cytokine; 2005 Feb; 29(3):125-34. PubMed ID: 15613280
[TBL] [Abstract] [Full Text] [Related]
